The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...
Gov. Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be ...
The MIND diet was associated with slower cognitive decline in both Black and white older adults, but relationships appeared ...
Medpage Today on MSN12h
Evidence of Durable Vision Improvement With Gene Therapy for Retinitis PigmentosaCHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...
Medpage Today on MSN4d
Gene Therapy Details Revealed in Duchenne TrialSAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, ...
Editas Medicines has signed a $238 million biobucks pact to combine Genevant Science’s lipid nanoparticle (LNP) tech with the ...
The biotech engaged with the FDA on alternative pathways to approval after seeing safety and efficacy data from the phase 1/2 ...
The National Institutes of Health has awarded an assistant professor of biomedical engineering about $1.8 million to study ...
Sidra Medicine s Genetic and Genomic Medicine clinic is providing life altering gene therapy for rare genetic disorders. In a ...
The first patient to undergo recently approved gene therapy for sickle cell disease, Kendric Cromer, has left the hospital.
The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...
The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for its clinical-stage treatment reni-cel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback